Italian Real-life obServational Study on the effecTiveness, sAfety and Tolerability of Atogepant in Migraine Patients

RecruitingOBSERVATIONAL
Enrollment

100

Participants

Timeline

Start Date

May 9, 2024

Primary Completion Date

September 30, 2025

Study Completion Date

April 30, 2026

Conditions
MigraineMigraine With AuraMigraine Without AuraChronic Migraine
Interventions
DRUG

Atogepant 60 mg

Patients using atogepant 60 mg tablet daily as migraine prevention

Trial Locations (2)

50134

RECRUITING

SOD Centro Cefalee e Farmacologia Clinica, AOU Careggi, Florence

00128

RECRUITING

Fondazione Policlinico Campus Bio-Medico, Roma

All Listed Sponsors
collaborator

Fondazione Policlinico Universitario Campus Bio-Medico

OTHER

collaborator

"IRCCS National Neurological Institute C. Mondino Foundation"

OTHER

collaborator

Società Italiana per lo Studio delle Cefalee

OTHER

collaborator

Azienda Ospedaliero-Universitaria Consorziale Policlinico di Bari

OTHER

collaborator

Università degli Studi dell'Aquila

OTHER

collaborator

University of Roma La Sapienza

OTHER

collaborator

Azienda Ospedaliero Universitaria Policlinico Modena

OTHER

collaborator

Euganea Health Unit, Padua, Italy

UNKNOWN

collaborator

Azienda Ospedaliero-Universitaria di Parma

OTHER

collaborator

Azienda Ospedaliera S. Maria della Misericordia

OTHER

collaborator

A.O.U. Città della Salute e della Scienza

OTHER

collaborator

Cliniche Humanitas Gavazzeni

OTHER

collaborator

University of Campania Luigi Vanvitelli

OTHER

collaborator

Ospedale Santo Stefano

OTHER

collaborator

Azienda Policlinico Umberto I

OTHER

collaborator

Auxologico San Luca

OTHER

collaborator

Asst Degli Spedali Civili Di Brescia

OTHER

lead

University of Florence

OTHER